Continuum Advisory »

Aim Immunotech shares owned by Continuum Advisory

Quarter-by-quarter ownership of Aim Immunotech (AIM) shares owned by Continuum Advisory from 13F filings

Historical chart of Continuum Advisory investment in Aim Immunotech

Tip: Access up to 7 years of quarterly data

All positions including Aim Immunotech held by Continuum Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aim Immunotech by Continuum Advisory

Quarter filed Position value Share count Share price at filing
2026-06-30 $142 500 0.28

More positions owned by Continuum Advisory

Apple Stock (AAPL)
Capital Group Dividend Value Etf Etf (CGDV)
Walmart Stock (WMT)
Micron Technology Stock (MU)
Jpmorgan Core Plus Bond Etf Etf (JCPB)
Pimco Multisector Bond Active Exchange-traded Fund Etf (PYLD)
Vanguard Morningstar Total Stock Market Etf Etf (VTI)
Capital Group Core Bond Etf Etf (CGCB)
Vanguard Extended Market Etf Etf (VXF)
Nvidia Corporation Stock (NVDA)
Microsoft Corp Stock (MSFT)
Invesco Qqq Trust Series I Etf (QQQ)
Amazon Stock (AMZN)
Vanguard S&p 500 Etf Etf (VOO)
Vanguard Total Bond Market Etf Etf (BND)

View all positions for Continuum Advisory

Top funds holding Aim Immunotech

Virtu Financial
Geode Capital Management
Hrt Financial
XTX Topco
Jane Street
Vanguard Fiduciary Trust
Ground Swell Capital
Goss Wealth Management
Tower Research Capital
Morgan Stanley
Continuum Advisory
Community Bank
Harbour Investments
Creative Financial Designs
Advisor Group Holdings

View all funds holding Aim Immunotech